EXHIBIT 10.1

Longport Announces 3 Year Distribution Agreement with U. S. Medical
Systems, Inc. for the Purchase Of 1,900 Scanners
--------------------------------------------------------------------------------

Swarthmore, PA - February 12, 2004 - Longport, Inc. (OTC BB: LPTI) announced
today that it has signed a distribution agreement with US Medical Systems, Inc,
to sell its Longport Digital Scanner through the U. S. Medical Systems
distribution network. The contract calls for the purchase of 300 machines in the
first year, 600 machines in year two, and 1,000 machines in year three.

An initial order, with a $500,000 deposit, has been placed for the first 100
machines with delivery starting in April 2004. This Agreement calls for LDS
units to be delivered at a rate of not less than 25 scanners per month in year
1, 50 units per month in year 2 and 80 units per month in year 3.

U.S. Medical Systems, Inc., a wholly owned subsidiary of Prime Rate Income &
Dividend Enterprises, Inc. (OTC BB:PIDV), will deliver the Longport model LDS-1
high resolution ultrasound scanner to physicians within networks of medical
clinics.

Michael C. Boyd, CEO, Longport, Inc. said, "Longport was very pleased to receive
such a large order for its Digital Scanner and that the Company was excited to
be working with U. S. Medical".

Peter Futro, Chairman of U. S. Medical Systems, Inc. commented "We are proud to
have the Longport LDS-1 as our first product. The LDS-1 has already received
marketing clearance from the FDA and we are currently in talks with multiple
healthcare networks who have expressed interest in placing the LDS-1 scanner in
their networks."

Longport, Inc. (OTC BB: LPTI) of Swarthmore, Pennsylvania, is a medical
technology company that specializes in affordable high-resolution ultrasound
imaging. After several years and some $3,000,000 of research and development,
during which Longport has secured patents, copyrights, FDA clearance and UL and
European CE marks Longport has introduced its LDS-1 into the wound prevention
and assessment, dermatology and aesthetics markets. In June 2002, Longport was
awarded a $500,000 grant by the Pennsylvania Department of Health to evolve its
established technology into a multi-element array system, with breast cancer
imaging being the application focus.

<PAGE>


U.S Medical is a development- stage marketing and distribution organization,
which provides medical devices and support services to the healthcare industry.
U.S. Medical focuses on its core competencies in sales and marketing and
outsource other functions such as manufacturing and related engineering and
product development. In most cases, products will be leased to either the
clinician performing the procedure or the affiliated clinics where the
procedures are performed. Generally, leased products will be shipped directly to
customers by the manufacturer and support services will be provided directly by
the manufacturer pursuant to agreements with U.S. Medical.


For further information please contact Longport, Inc. at 1-800-289-6863



Forward-looking Information and the Private Securities
------------------------------------------------------
Litigation Reform Act of 1995
-----------------------------
Certain statements in this press release, including statements concerning
product development milestones and anticipated events, are "forward-looking
statements" within the Private Litigation Reform Act of 1995. Forward Looking
Statements are based on the opinions and estimates of management at the time the
statements are made and are subject to certain risks and uncertainties that
could cause actual results to differ materially from those anticipated in the
forward-looking statements. The words "believe," "expect," "intend,"
"anticipate," variations of such words, and similar expressions identify
forward-looking statements, but their absence does not mean that the statement
is not forward-looking. These statements are not guarantees of future
performance and are subject to certain risks, uncertainties and assumptions that
are difficult to predict. Factors that could affect Longport's actual results
include, among others, uncertainties as to the Company's ability to manage
potential problems, delays or anticipated expenses, including problems, delays
or expenses involving manufacturing. Readers are cautioned not to place undue
reliance upon these forward-looking statements that speak only to the date of
this release. Reference is made to Longport's 2002 annual report on Form 10-K
filed with the Securities and Exchange Commission for a more definitive
description of such factors. Longport, Inc. undertakes no obligation to update
publicly any forward-looking statements to reflect new information, events or
circumstances after the date of this release or to reflect the occurrence of
unanticipated events.